A

Annovis Bio

D

ANVS

USD

0.31

(3.6993%)

Market Closed

4,035.00

حجم التداول

-1.7

الربح لكل سهم

-

العائد الربحي

-1.914097

P/E

113,439,416.42

حجم السوق

اليوم

3.6993%

1 اسبوع

3.084%

1 شهر

-3.013%

6 اشهر

-3.444%

12 اشهر

-17.630%

بداية السنة

-53.653%

كل الوقت

0%

أصول ذات صلة

Title:
Annovis Bio

Sector:

Healthcare

Industry:

Biotechnology

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا